ST. LOUIS, March 15, 2019 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading specialty pharmaceutical company, announced today that sites owned and operated by subsidiaries in its Specialty Generics business have been recognized as Manufacturing Leadership Award winners for outstanding achievement. The awards, granted by the National Association of Manufacturers, were received in two categories – Talent Management Leadership as well as Engineering and Production Technology Leadership.
The Specialty Generics business' Hobart, N.Y., manufacturing site earned the Talent Management Leadership award. This is the second consecutive year the site was recognized, winning three awards in 2018 for its highly successful implementation of key two-year initiatives designed to enhance multiple aspects of its manufacturing operations. This year's award highlights the site's Training Strategy Deployment project, part of a multi-year initiative, and focused on strengthening employee skill sets to bolster company agility and better support customers' needs and expectations. Through implementing a "70/20/10" training model – 70% hands-on, 20% coached and 10% classroom – the changes resulted in creating a more agile work environment and instilled a greater sense of pride among employees.
Specialty Generics' St. Louis, Mo., facility was recognized with the Engineering and Production Technology Leadership award based on its seven-year Chemistry and Facility Modernization initiative. This transformational, multi-faceted project sought to modernize processes and production while reducing operating costs and regulatory risks. Upon completing the initiative, a new production facility was opened, and significant savings, process improvements and efficiencies were realized, along with expanded site capacity.
"We are very pleased our Hobart and St. Louis sites have been recognized for manufacturing leadership by the National Association of Manufacturers," said Matthew Harbaugh, President, Specialty Generics for Mallinckrodt. "We are proud of the employees' efforts at both sites to become premier manufacturing operations to ensure we are both suppliers and employers of choice."
Harbaugh continued, "As we prepare for the planned separation of our Specialty Generics and Amitiza® business during the second half of 2019, retaining the legacy Mallinckrodt name associated with our founding in St. Louis more than 150 years ago, manufacturing excellence at all our sites will be vital to our success as an independent, publicly traded company."
Mallinckrodt will be recognized at the 15th Annual Manufacturing Leadership Awards Gala, which is to be held on the last day of the Manufacturing Leadership Summit, June 10-12, 2019 at the Hyatt Regency Huntington Beach Resort and Spa in Huntington Beach, CA.
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The company's Specialty Brands reporting segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; and analgesics. Its Specialty Generics and Amitiza reporting segment includes specialty generic drugs, active pharmaceutical ingredients and AMITIZA® (lubiprostone). To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Mallinckrodt uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the company in advance of or in lieu of distributing a press release or a filing with the U.S. Securities and Exchange Commission disclosing the same information. Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations page of the website.
About the Manufacturing Leadership Awards
The Manufacturing Leadership (ML) Awards, now in their 15th year, honor manufacturing companies and individual manufacturing leaders that are shaping the future of global manufacturing. Winning projects and individual manufacturing leaders have demonstrated achievement in one of a wide range of categories, and are chosen by a panel of expert judges for results that have delivered clear and compelling value, return on investment, and other tangible outcomes. There will be several winners in each category, including one High Achiever's Award in each category, as well as a 2019 Manufacturer of the Year for both small and large enterprises. Also unveiled at the Gala will be the ML Awards Manufacturing Leader of the Year and Lifetime Achievement Award winners.
The theme for the 15th Annual Manufacturing Leadership Summit is "Strategies to Deliver Business Value Through Manufacturing 4.0." The event enables senior-level executives in all aspects of manufacturing an opportunity to network with and learn from the best minds in the industry.
For more information on the Manufacturing Leadership Awards or the Manufacturing Leadership Summit, please go to www.mlsummit.com.
About the National Association of Manufacturers
The National Association of Manufacturers (NAM) is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs more than 12 million men and women, contributes $2.25 trillion to the U.S. economy annually, has the largest economic impact of any major sector and accounts for more than three-quarters of all private-sector research and development in the nation. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States.
The NAM's world-class staff of policy experts provide unmatched access and information on the key issues affecting your business and bottom line. We are on the front lines of a wide range of policy battles, from immigration reform and labor relations, to energy and the environment, to trade policy and taxes. At every turn, we are working on behalf of manufacturers in America to advance policies that help manufacturers do what they do best: create economic strength and jobs. www.nam.org
Daniel J. Speciale, CPA
Vice President, Investor Relations and IRO
Mallinckrodt, the "M" brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their respective owners. © 2019 Mallinckrodt. 03/19
SOURCE Mallinckrodt Pharmaceuticals